Drugmakers have unlawfully colluded to prevent competition for a generic numbing ointment as well as treatments for gallbladder stones, seizures and eczema, consequently inflating prices paid by direct purchasers, according to four separate antitrust suits filed Tuesday as part of multidistrict litigation in Pennsylvania federal court.
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Direct access to case information and documents.
All significant new filings across U.S. federal district courts, updated hourly on business days.
Full-text searches on all patent complaints in federal courts.